Simpson Thacher represented the dealer managers in connection with the cash tender offers (i) by Viatris Inc. (“Viatris”) to purchase any and all of its outstanding 1.650% Senior Notes due 2025, (ii) by Mylan Inc., a wholly-owned subsidiary of Viatris, to purchase any and all of its outstanding 2.125% Senior Notes due 2025 and (iii) by Utah Acquisition Sub Inc., a wholly-owned subsidiary of Viatris, to purchase up to $575 million aggregate principal amount of its outstanding 3.950% Senior Notes due 2026.~~Viatris is a global healthcare company bridging the traditional divide between generics and brands to more holistically address healthcare needs globally. Viatris provides access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually. Viatris is headquartered in the United States, with global centers in Pittsburgh, Shanghai and Hyderabad, India.~~The Simpson Thacher team included John C. Ericson, Traci Biedermann and Deniz Demirci (Capital Markets); and Jonathan Cantor (Tax).